Abstract
No longer are healthcare-acquired conditions considered expected costs of care. Given the lack of randomized controlled trials in children, often we are left with extrapolating from adult literature, recommended prevention bundles, and expert opinion. Additionally, strategies that are considered adjunct to the standard prevention bundles have been examined. Here, we review standard central line-associated bloodstream infection (CLABSI) prevention bundles as well as adjunct prevention strategies. Due to the mortality and morbidity risk, indirect and direct costs, and the inevitable penalties associated with these largely preventable harms, we must reliably implement bundles to avoid these healthcare-acquired infections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
